Lake Street Downgrades Assertio Therapeutics (ASRT) to Hold

April 9, 2026 8:43 AM

Lake Street analyst Thomas Flaten downgraded Assertio Therapeutics (NASDAQ: ASRT) from Buy to Hold with a price target of $18.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found